Cerebrospinal fluid markers including trefoil factor 3 are associated with neurodegeneration in amyloid-positive individuals
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cerebrospinal fluid markers including trefoil factor 3 are associated with neurodegeneration in amyloid-positive individuals
Authors
Keywords
-
Journal
Translational Psychiatry
Volume 4, Issue 7, Pages e419-e419
Publisher
Springer Nature
Online
2014-07-29
DOI
10.1038/tp.2014.58
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Association of genetic variants with cerebrospinal fluid protein levels of ACE, MMP3 and other proteins and risk for Alzheimer's disease
- (2013) John Kauwe et al. Alzheimers & Dementia
- Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
- (2013) Clifford R Jack et al. LANCET NEUROLOGY
- Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study
- (2013) Victor L Villemagne et al. LANCET NEUROLOGY
- Vascular and Alzheimer's disease markers independently predict brain atrophy rate in Alzheimer's Disease Neuroimaging Initiative controls
- (2013) Josephine Barnes et al. NEUROBIOLOGY OF AGING
- Effects of cerebrospinal fluid proteins on brain atrophy rates in cognitively healthy older adults
- (2013) Niklas Mattsson et al. NEUROBIOLOGY OF AGING
- Atrophy Rates in Asymptomatic Amyloidosis: Implications for Alzheimer Prevention Trials
- (2013) K. Abigail Andrews et al. PLoS One
- VEGF significantly restores impaired memory behavior in Alzheimer's mice by improvement of vascular survival
- (2013) Piotr Religa et al. Scientific Reports
- CSF protein biomarkers predicting longitudinal reduction of CSF β-amyloid42 in cognitively healthy elders
- (2013) N Mattsson et al. Translational Psychiatry
- Upcoming candidate cerebrospinal fluid biomarkers of Alzheimer’s disease
- (2012) Anne M Fagan et al. Biomarkers in Medicine
- Multicenter, Randomized, Double-Blind, Placebo-Controlled, Single-Ascending Dose Study of the Oral γ-Secretase Inhibitor BMS-708163 (Avagacestat): Tolerability Profile, Pharmacokinetic Parameters, and Pharmacodynamic Markers
- (2012) Gary Tong et al. CLINICAL THERAPEUTICS
- Involvement of dopaminergic neuronal cystatin C in neuronal injury-induced microglial activation and neurotoxicity
- (2012) Garima Dutta et al. JOURNAL OF NEUROCHEMISTRY
- Cystatin C in Alzheimer's disease
- (2012) Gurjinder Kaur et al. Frontiers in Molecular Neuroscience
- Neuropeptide Trefoil factor 3 improves learning and retention of novel object recognition memory in mice
- (2011) Hai-Shui Shi et al. BEHAVIOURAL BRAIN RESEARCH
- Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
- (2010) Kaj Blennow et al. Nature Reviews Neurology
- Reduced sample sizes for atrophy outcomes in Alzheimer's disease trials: baseline adjustment
- (2010) J.M. Schott et al. NEUROBIOLOGY OF AGING
- Automated cross-sectional and longitudinal hippocampal volume measurement in mild cognitive impairment and Alzheimer's disease
- (2010) Kelvin K. Leung et al. NEUROIMAGE
- Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects
- (2009) Leslie M. Shaw et al. ANNALS OF NEUROLOGY
- The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods
- (2008) Clifford R. Jack et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- Abnormal TDP-43 immunoreactivity in AD modifies clinicopathologic and radiologic phenotype
- (2008) K. A. Josephs et al. NEUROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started